Belmonti, Simone
 Distribuzione geografica
Continente #
NA - Nord America 210
EU - Europa 134
AS - Asia 65
AF - Africa 8
SA - Sud America 1
Totale 418
Nazione #
US - Stati Uniti d'America 208
SE - Svezia 42
IT - Italia 38
CN - Cina 29
SG - Singapore 18
DE - Germania 13
IE - Irlanda 10
FR - Francia 9
IN - India 9
CM - Camerun 8
GB - Regno Unito 5
ID - Indonesia 5
FI - Finlandia 4
BE - Belgio 3
PL - Polonia 3
UA - Ucraina 3
CA - Canada 2
HK - Hong Kong 2
BY - Bielorussia 1
EC - Ecuador 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
NL - Olanda 1
RU - Federazione Russa 1
Totale 418
Città #
Chandler 48
Ann Arbor 19
New York 12
Singapore 12
Ashburn 11
Cattolica 11
Dublin 10
Jacksonville 10
Redwood City 8
San Mateo 8
Nanjing 6
Woodbridge 6
Jakarta 5
Houston 4
Lancaster 4
Milan 4
Rome 4
Boston 3
Brussels 3
Kraków 3
Princeton 3
Wilmington 3
Auburn Hills 2
Beijing 2
Boardman 2
Cambridge 2
Ciampino 2
Dearborn 2
Fairfield 2
Hong Kong 2
Lawrence 2
Ottawa 2
Paris 2
Shenyang 2
Tianjin 2
Amsterdam 1
Andover 1
Berlin 1
Chongqing 1
Dallas 1
Frankfurt am Main 1
Guangzhou 1
Guayaquil 1
Harbin 1
Hebei 1
Hefei 1
Jiaxing 1
Jinan 1
Mountain View 1
Nanchang 1
Nizhniy Novgorod 1
Norwalk 1
Pomezia 1
Pune 1
Seattle 1
Shenzhen 1
Simi Valley 1
Tokyo 1
Velletri 1
Vitebsk 1
Wuxi 1
Totale 249
Nome #
Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study 100
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine versus the 23-valent polysaccharide vaccine in unvaccinated HIV-infected adults: A pilot, prospective controlled study 96
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 89
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA 86
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy 57
Totale 428
Categoria #
all - tutte 1.812
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.812


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202026 0 0 0 0 0 0 4 0 0 0 18 4
2020/202142 16 2 0 2 4 6 5 2 2 0 2 1
2021/202256 2 1 1 7 3 2 2 9 4 4 9 12
2022/2023116 21 18 7 18 7 11 1 13 17 1 2 0
2023/202462 3 18 6 7 1 14 2 0 0 0 11 0
2024/202529 0 1 6 6 11 4 1 0 0 0 0 0
Totale 428